Systemic lupus erythematosus and dysregulated apoptosis - What is the evidence?

Rheumatology

Volumn 41, Issue 3, 2002, Pages 242-245

  McHugh, N J ^a  

^a ROYAL NATIONAL HOSPITAL FOR RHEUMATIC DISEASES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CHLORPROMAZINE; DEOXYRIBONUCLEASE I; DNA FRAGMENT; FAS ANTIGEN; FAS LIGAND; FC RECEPTOR; GRANZYME B; INTERLEUKIN 10; MANNOSE BINDING PROTEIN; PHOSPHATIDYLSERINE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); SALAZOSULFAPYRIDINE; SILICON DIOXIDE; STEROID; TETRAMER;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTING CELL; APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CHROMATIN CONDENSATION; CHROMOSOME 1; CLINICAL FEATURE; COMPLEMENT DEFICIENCY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG RESISTANCE; EDITORIAL; GENE DELETION; GENETIC DISORDER; GENETIC POLYMORPHISM; HEREDITY; HUMAN; IMMUNE RESPONSE; IMMUNOADSORPTION; INFLAMMATION; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; LYMPHOPROLIFERATIVE DISEASE; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; RETICULOENDOTHELIAL SYSTEM; SKIN LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; APOPTOSIS; DOWN-REGULATION; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 0036106267     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (26)

1. The biochemistry of apoptosis
2. Corpse clearance defines the meaning of cell death
3. Fas and Fas ligand: Lpr and gld mutations
4. Features of systemic lupus erythematosus in Dnasel-deficient mice
5. Homozygous Clq deficiency causes glomerulonephritis associated with multiple apoptotic bodies
6. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity
7. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease
8. Autoimmune lymphoproliferative syndrome, a disorder of apoptosis
9. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule
10. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus
11. Clq and systemic lupus erythematosus
12. A dysfunctional allele of the mannose binding protein gene associates with systemic lupus erythematosus in a Spanish population
13. The Fegamma receptor 111A-158F allele is a major risk factor for the development of lupus nephritis among Caucasians but not non-Caucasians
14. Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus
15. PARP alleles within the linked chromosomal region are associated with systemic lupus erythematosus
16. The antiinflammatory drug sulfasalazine inhibits tumor necrosis factor alpha expression in macrophages by inducing apoptosis
17. Chlorpromazine induces apoptosis in activated human lymphoblasts: A mechanism supporting the induction of drug-induced lupus erythematosus?
18. Silica-induced apoptosis mediated via scavenger receptor in human alveolar macrophages
19. Endogenous circulating DNA in systemic lupus erythematosus. Occurrence as multimeric complexes bound to histone
20. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes
21. Cleavage by granzyme B is strongly predictive of autoantigen status: Implications for initiation of autoimmunity
22. Remnants of suicidal cells fostering systemic autoaggression. Apoptosis in the origin and maintenance of autoimmunity
23. Apoptotic cell clearance in systemic lupus erythematosus. II. Role of beta2-glycoprotein I
24. Apoptotic cell clearance in systemic lupus erythematosus. I. Opsonization by antiphospholipid antibodies
25. Apoptosis of lymphocytes induced by glucocorticoids and relationship to therapeutic efficacy in patients with systemic lupus erythematosus
26. Successful treatment of patients with systemic lupus erythematosus by immunoadsorption with a Clq column: A pilot study